Families mourning 3 who attended college together after deadly metro Atlanta crash
The parents were among the three people who died in the crash.
Channel 2's Tyisha Fernandes spoke to an investigator who said they're still trying to figure out why the car crashed.
The victims' families are focusing on their faith to get them through this tragedy.
The Lawrence family is having a hard time accepting the loss of Varick Lawrence, Jr.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
Many people called him 'Champ' because he fought to survive at birth.
'It just stuck, and they kept saying he's a little champion,' his grandmother, Dot Mitchell said.
His parents say he was also a champion in baseball, his favorite sport. He played on the team at Stillman College in Alabama with his friend Sieas Elliot, who also died in Saturday's crash.
The third victim was Lawrence's girlfriend and future wife, Destiny Gardner.
They had a son, Zaire, together. He's just nine months old.
'We should be planning a wedding, not funerals,' Mitchell said.
There is a GoFundMe campaign set up to benefit the family of Sieas Elliott.
TRENDING STORIES:
Man killed in shooting at Atlanta park
Police ask for help identifying man they say shot, killed homeowner during robbery
Man sentenced to nearly 6 years for buying 150+ guns in GA, trying to smuggle them to Mexico
[SIGN UP: WSB-TV Daily Headlines Newsletter]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Piper Sandler Reiterates a Buy Rating on UnitedHealth Group (UNH)
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best stocks to invest in for beginners. Piper Sandler analyst Jessica Tassan reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on August 5, setting a price target of $280.00. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) reported that its Q2 2025 revenue underwent a $12.8 billion year-over-year growth to $111.6 billion, attributed primarily to growth within Optum and UnitedHealthcare. Earnings from operations for the quarter were $5.2 billion, while adjusted net earnings were $4.08 per share. Management reported a full year 2025 revenue outlook in the $445.5 billion to $448.0 billion range, with a full year 2025 earnings outlook of at least $14.65 per share. UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
UFC heavyweight suspended for doping violation
UFC heavyweight suspended for doping violation originally appeared on The Sporting News The UFC career of Alvin Hines is in serious jeopardy. The heavyweight, who lost his Octagon debut at UFC 317 earlier this year, has been suspended for a year after a failed drug test. Hines, who took a bout with Jhonata Diniz on short notice in June, tested positive for the anabolic steroid Drostanolone, the promotion announced. The test results were released by Combat Sports Anti-Doping (CSAD). MORE: Dana White still has trust with Conor McGregor to make big fights A native of Minnesota, Hines was also found to have 3a-Hydroxy-2a-methyl-5a-androstan-17-one and testosterone metabolites, as well as a metabolite of Tamoxifen, 3-Hydroxy-4-methooxytamoxifen, a hormone and metabolic modulator in his system. The tests were take from samples collected both in-competition and out-of-competition. In the release, the UFC noted that the cases reflected that Hines consumed the substances that are banned before he was signed to the UFC, but that he also failed to disclose taking them when his onboarding into the UFC Anti-Doping Program was completed just days before his bout. "Under the UFC ADP, CSAD evaluates each case and can reduce periods of ineligibility based on the athlete's degree of fault and their level of cooperation," the UFC said in a statement. " While Hines failed to disclose his prior use of these substances during onboarding, the estimated concentrations of these substances in Hines' samples were reflective that they were near the tail end of excretion and supported his explanation of their use prior to being signed to the UFC and entering the UFC registered testing pool." The suspension started on July 11, 2025 and runs for one year. MORE COMBAT SPORTS NEWS: PFL sets pair of championship matches for upcoming event How to watch UFC in 2026 on Paramount+ Alexander Volkanovski previews UFC 319 co-main event Complete MMA schedule for 2025
Yahoo
22 minutes ago
- Yahoo
Jim Cramer on UnitedHealth: 'It Could Come Back'
UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer shed light on. Cramer showed a slight bit of optimism toward the company as he said: 'I think UnitedHealth's going to work here… I think it's going to work. I really do. Look, I'm not a believer. I don't like the fact that they had shenanigans, but I will say this: I think that the company is run by a very good CEO. It could come back.' Ken Wolter/ UnitedHealth Group Incorporated (NYSE:UNH) provides health benefits, pharmacy care, care delivery, and health management services. In addition, the company offers data analytics and technology-driven solutions for individuals, employers, governments, and health systems. During the August 7 episode, when a caller inquired about the company stock, Cramer responded: 'I have long known, this is something I learned probably in my second decade of trading or investing: You do not buy or sell something where you have no idea what is really happening. And at UnitedHealth, there isn't anyone other than the CEO and probably 52,000 lawyers who has any idea what's going on.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
